These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology]. Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. Arankalle VA; Lole KS; Deshmukh TM; Chobe LP; Gandhe SS J Viral Hepat; 2007 Jun; 14(6):435-45. PubMed ID: 17501765 [TBL] [Abstract][Full Text] [Related]
6. [Cloning, sequencing and expression of hepatitis E virus structural gene in E. coli and application of the recombinant products for diagnosis]. Rong G; Sun J; Zhou J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):169-72. PubMed ID: 12515200 [TBL] [Abstract][Full Text] [Related]
7. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Zhang Y; McAtee P; Yarbough PO; Tam AW; Fuerst T Clin Diagn Lab Immunol; 1997 Jul; 4(4):423-8. PubMed ID: 9220158 [TBL] [Abstract][Full Text] [Related]
8. [Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha]. Su CX; Gu MR; Zhang P; Jin ZJ; Meng FH; Chen EJ; Yang Z; Liu Y; Wang YC Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):73-8. PubMed ID: 17366891 [TBL] [Abstract][Full Text] [Related]
9. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M. Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540 [TBL] [Abstract][Full Text] [Related]
11. The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep. Li F; Loke P; Healy A; Lightowlers MW; Gauci CG; Purcell DF; Anderson DA Vaccine; 2006 Feb; 24(9):1367-77. PubMed ID: 16242219 [TBL] [Abstract][Full Text] [Related]
12. A new artificial antigen of the hepatitis E virus. Ulanova TI; Obriadina AP; Talekar G; Burkov AN; Fields HA; Khudyakov YE J Immunoassay Immunochem; 2009; 30(1):18-39. PubMed ID: 19117200 [TBL] [Abstract][Full Text] [Related]
13. Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco. Meng J; Cong M; Dai X; Pillot J; Purdy MA; Fields HA; Khudyakov YE J Med Virol; 1999 Feb; 57(2):126-33. PubMed ID: 9892396 [TBL] [Abstract][Full Text] [Related]
14. [Expression of full-length hepatitis E virus structural gene using baculovirus expression system]. Zhang M; Yi Y; Liu C; Bi S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):354-6. PubMed ID: 12665904 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Takahashi M; Yamada K; Hoshino Y; Takahashi H; Ichiyama K; Tanaka T; Okamoto H Arch Virol; 2008; 153(9):1703-13. PubMed ID: 18679765 [TBL] [Abstract][Full Text] [Related]
16. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris]. Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572 [TBL] [Abstract][Full Text] [Related]
17. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027 [TBL] [Abstract][Full Text] [Related]
18. [Vaccination of rhesus monkeys with recombinant antigen fragments and protection from hepatitis E virus infection]. Ma YB; Xie TH; Zhang GM; Li CH; Dai XJ; Dai CB; Sun MS; Lu J; Bi SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):592-5. PubMed ID: 12905686 [TBL] [Abstract][Full Text] [Related]
19. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Zhou YH; Purcell RH; Emerson SU Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215 [TBL] [Abstract][Full Text] [Related]
20. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV]. Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]